Clinical Trials Sponsored by Mochida Pharmaceutical Company, Ltd

Total 55 results

Mochida Pharmaceutical Company, Ltd.

Completed

Efficacy of MND-2119 in Participants With Hypertriglyceridemia

Hypertriglyceridemia

Japan
Mochida Pharmaceutical Company, Ltd.

Completed

Study Evaluating Single Ascending Doses of MR1817

Adult

United Kingdom
Mochida Pharmaceutical Company, Ltd.

Completed

Long-term Safety and Efficacy Study of MND-2119 in Patients With Hypertriglyceridemia

Hypertriglyceridemia

Japan
Mochida Pharmaceutical Company, Ltd.

Completed

Utility of Presepsin in Distinguishing Between Sepsis and SIRS

Sepsis | SIRS

United States
Mochida Pharmaceutical Company, Ltd.

Completed

Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

Steatohepatitis

United States, Puerto Rico
Mochida Pharmaceutical Company, Ltd.
Pfizer

Completed

A Study of MD-120 in Patients With Depression

Major Depressive Disorder

Japan
Kobe University
Mochida Pharmaceutical Company, Ltd.

Completed

Protective Effect of EPA on Cardiovascular Events

Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Subjects With Hepatic Insufficiency)

Hepatic Insufficiency | Healthy

Japan
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Study of FYU-981 in Hyperuricemic Outpatients With or Without Gout (Effect on Two Hyperuricemic Types)

Hyperuricemia With or Without Gout

Japan
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Mass Balance Study of FYU-981

Healthy Male Subjects

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Clinical Pharmacology of FYU-981 (Final Formulation)

Healthy

Japan
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Completed

A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Drug-drug Interaction Study of FYU-981 and Oxaprozin

Healthy

Japan
Fuji Yakuhin Co., Ltd.
Mochida Pharmaceutical Company, Ltd.

Completed

Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
Mochida Pharmaceutical Company, Ltd.
Fuji Yakuhin Co., Ltd.

Completed

Febuxostat-Controlled, Double-Blind, Comparative Study of FYU-981 in Hyperuricemia With or Without Gout

Hyperuricemia With or Without Gout

Japan
LG Life Sciences
Mochida Pharmaceutical Company, Ltd.

Unknown

A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Arthritis, Rheumatoid

Japan, Korea, Republic of
Mochida Pharmaceutical Company, Ltd.
Sumitomo Pharma (Suzhou) Co., Ltd.

Active, not recruiting

Efficacy of Ethyl Icosapentate in Patients With Severe Hypertriglyceridemia

Hypertriglyceridemia

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

The Mass Balance Study of LP-168 in Healthy Subjects

Clinical Pharmacology

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Active, not recruiting

A Study of LP-128 Capsules in Healthy Subjects

Chronic Hepatitis b

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Food Effect Study of LP-168 Tablets in Healthy Subjects

Mantle Cell Lymphoma

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Study of LP-168 in Healthy Volunteers

Multiple Sclerosis | NMO Spectrum Disorder

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

Phase Ib Study of Rocbrutinib in Combination With R-CHOP in Patients With Newly Diagnosed B-cell Non-Hodgkin Lymphoma

B-cell Non-Hodgkin Lymphoma

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-168 in Participants With Relapse or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma (MCL)

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-118 in Patients With Advanced Tumors

Lymphoma, Non-Hodgkin | Solid Tumor

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia

China
Guangzhou Lupeng Pharmaceutical Company LTD.

Recruiting

A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma

B-cell Lymphoma

China
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Recruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

Migraine

United States, France, Spain, Poland, Canada, Italy
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Active, not recruiting

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Migraine

Spain, United States, France, Canada, Germany, United Kingdom, Poland, Austria, Sweden, Italy
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Active, not recruiting

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

United States
Pfizer
Biohaven Pharmaceutical Holding Company Ltd.

Terminated

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Temporomandibular Disorders (TMD)

United States
Beijing Grand Johamu Pharmaceutical Company, Ltd.

Recruiting

A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia

Community-acquired Pneumonia

China
Suzhou Raymon Pharmaceuticals Company, Ltd.
WuXi Clinical

Active, not recruiting

RMP-A03 Ocular Suspension in Patients With Pterygium

Pterygium

United States
POLYSAN Scientific & Technological Pharmaceutical...
Atlant Clinical Ltd.

Completed

Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients

Metabolic Acidosis

Russian Federation
Shanghai Zhangjiang Biotechnology Limited Company
Shanghai Biomabs Pharmaceutical Co., Ltd.

Completed

Study of CMAB009 to Treat KRAS Wild Type Metastatic Colorectal Cancer (CRC009)

Metastatic Colorectal Cancer
Joint Stock Company "Farmak"
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Recruiting

Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel

Rheumatoid Arthritis

Ukraine
Yooyoung Pharmaceutical Co., Ltd.
Opera CRO, a TIGERMED Group Company

Not yet recruiting

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of ORTHIX PLUS

Osteoarthritis, Knee | Degenerative Joint Disease of Knee
Yooyoung Pharmaceutical Co., Ltd.
Opera CRO, a TIGERMED Group Company

Not yet recruiting

Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO

Osteoarthritis | Degenerative Joint Disease
Xi'An Aolitai Pharmaceutical Technology Co Ltd

Recruiting

A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Drug-Induced Liver Injury | Cholestatic Liver Injury | Mixed Liver Injury

China
Zhejiang Hisun Pharmaceutical Co. Ltd.
Opera CRO, a TIGERMED Group Company

Unknown

A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19

COVID-19

China, Germany, Romania
The First Affiliated Hospital with Nanjing Medical...
Guangzhou Lupeng Pharmaceutical Company LTD.; Newave Pharmaceutical Inc

Recruiting

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma

China
Pfizer
Eli Lilly and Company; Merck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co....

Recruiting

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Neoplasms

Canada, United States, Taiwan, Belgium, Korea, Republic of, Australia, China, Spain, New Zealand, Japan, Denmark, Germany, Netherlands, Italy, Russian Federation, Finland, Bulgaria, Czechia, India, Mexico, Slovakia, South Africa, Uk... and more
Andrew Ko
Eli Lilly and Company; Taiho Pharmaceutical Co., Ltd.

Terminated

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Not yet recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone

Post Traumatic Stress Disorder
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Recruiting

Department of Defense PTSD Adaptive Platform Trial Intervention A - Fluoxetine

Post Traumatic Stress Disorder

United States
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Recruiting

Department of Defense PTSD Adaptive Platform Trial - Master Protocol

Post Traumatic Stress Disorder

United States
U.S. Army Medical Research and Development Command
PPD; Idorsia Pharmaceuticals Ltd.; Berry Consultants; Cambridge Cognition Ltd; Ci...

Recruiting

Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant

Post Traumatic Stress Disorder

United States
The 458 Hospital of Chinese PLA
Guangzhou Baidi Biotechnology Co., Ltd; Guangzhou Pharmaceucal Company Limited

Unknown

A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B

Chronic Hepatitis B Patients With HBeAg-positive

China
Syneos Health
Bristol-Myers Squibb; Merck Sharp & Dohme LLC; AbbVie; Gilead Sciences; Janssen Scientific... and other collaborators

Recruiting

Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. (APR)

HIV Infections | Hepatitis B

United States
Central Hospital, Nancy, France
Sanofi; GlaxoSmithKline; Zambon SpA; Laboratoires URGO; Pierre Fabre Medicament; Bi... and other collaborators

Unknown

Allergy to Neuromuscular Blocking Agents and Pholcodine Exposure (ALPHO)

Neuromuscular Blocking Agents Anaphylaxis

France

Clinical Trials Sponsored by Mochida Pharmaceutical Company, Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations